These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34728798)

  • 1. Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry.
    Sanchez-Roige S; Fontanillas P; Jennings MV; Bianchi SB; Huang Y; Hatoum AS; Sealock J; Davis LK; Elson SL; ; Palmer AA
    Mol Psychiatry; 2021 Nov; 26(11):6209-6217. PubMed ID: 34728798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.
    Sanchez-Roige S; Palmer AA; Fontanillas P; Elson SL; ; Adams MJ; Howard DM; Edenberg HJ; Davies G; Crist RC; Deary IJ; McIntosh AM; Clarke TK
    Am J Psychiatry; 2019 Feb; 176(2):107-118. PubMed ID: 30336701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci.
    Deak JD; Zhou H; Galimberti M; Levey DF; Wendt FR; Sanchez-Roige S; Hatoum AS; Johnson EC; Nunez YZ; Demontis D; Børglum AD; Rajagopal VM; Jennings MV; Kember RL; Justice AC; Edenberg HJ; Agrawal A; Polimanti R; Kranzler HR; Gelernter J
    Mol Psychiatry; 2022 Oct; 27(10):3970-3979. PubMed ID: 35879402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.
    Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J;
    JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents.
    Carmona J; Maxwell JC; Park JY; Wu LT
    J Adolesc Health; 2020 May; 66(5):536-544. PubMed ID: 31964613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study.
    Papadomanolakis-Pakis N; Moore KM; Peng Y; Gomes T
    Drug Alcohol Depend; 2021 Apr; 221():108601. PubMed ID: 33618194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study.
    Cai J; He L; Wang H; Rong X; Chen M; Shen Q; Li X; Li M; Peng Y
    Addiction; 2022 May; 117(5):1382-1391. PubMed ID: 34859517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
    J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.
    Guillou-Landreat M; Quinio B; Le Reste JY; Le Goff D; Fonsecca J; Grall-Bronnec M; Dany A
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorder.
    Varisco T; Shen C; Thornton D
    J Subst Abuse Treat; 2020 Oct; 117():108073. PubMed ID: 32811630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.
    Song W; Kossowsky J; Torous J; Chen CY; Huang H; Mukamal KJ; Berde CB; Bates DW; Wright A
    Drug Alcohol Depend; 2020 Dec; 217():108276. PubMed ID: 32961455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.
    Anne S; Mims JW; Tunkel DE; Rosenfeld RM; Boisoneau DS; Brenner MJ; Cramer JD; Dickerson D; Finestone SA; Folbe AJ; Galaiya DJ; Messner AH; Paisley A; Sedaghat AR; Stenson KM; Sturm AK; Lambie EM; Dhepyasuwan N; Monjur TM
    Otolaryngol Head Neck Surg; 2021 Apr; 164(2_suppl):S1-S42. PubMed ID: 33822668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis.
    Rosoff DB; Smith GD; Lohoff FW
    JAMA Psychiatry; 2021 Feb; 78(2):151-160. PubMed ID: 33175090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse.
    Troiani V; Crist RC; Doyle GA; Ferraro TN; Beiler D; Ranck S; McBryan K; Jarvis MA; Barbour JS; Han JJ; Ness RJ; Berrettini WH; Robishaw JD
    BMC Med Genomics; 2021 Oct; 14(1):253. PubMed ID: 34702274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two data-driven approaches to identifying the spectrum of problematic opioid use: A pilot study within a chronic pain cohort.
    Schirle L; Jeffery A; Yaqoob A; Sanchez-Roige S; Samuels DC
    Int J Med Inform; 2021 Dec; 156():104621. PubMed ID: 34673309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Prescription Opioid and Nonopioid Analgesic Use by Race, 1996-2017.
    Cho G; Chang VW
    Am J Prev Med; 2022 Mar; 62(3):422-426. PubMed ID: 35190102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid use disorder in cancer patients.
    Lewis CES; Schutzer-Weissmann J; Farquhar-Smith P
    Curr Opin Support Palliat Care; 2023 Jun; 17(2):98-103. PubMed ID: 36866646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.